Patents by Inventor Jeff Schell

Jeff Schell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6583336
    Abstract: The present invention relates to a novel process for the production of transgenic organisms or transgenic cells, to transgenic orgaisms or transgenic cells obtainable by the process of the present invention, to the use of vectors comprising DNA encoding a recombination promoting enzymes for curing impairments caused by environmental influences in plants or plant cells and for gene therapy in mammals or mammalian cells, and to novel vectors.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: June 24, 2003
    Assignee: BASF Plant Science GmbH
    Inventors: Bernd Reiss, Hans Kosak, Manfred Klemm, Jeff Schell
  • Publication number: 20010020300
    Abstract: Transgenic pathogen-resistant organism whose genome contains at least two different genes under the control of active promoters with pathogen-inhibiting action. This organism is distinguished by a synergistic pathogen-inhibiting action. This action is evident particularly when the genes code for the gene products chitinase (ChiS, ChiG), glucanase (GluG), protein synthesis inhibitor (PSI) and antifungal protein (AFP).
    Type: Application
    Filed: August 24, 1998
    Publication date: September 6, 2001
    Inventors: JURGEN LOGEMANN, GUIDO JACH, BIRGIT GORNHARDT, JOHN MUNDY, JEFF SCHELL, PETER ECKES, ILAN CHET
  • Patent number: 6271442
    Abstract: Described are a method of producing pathogen-resistant plants in which a protein-synthesis inhibitor gene or a fusion product of the protein-synthesis inhibitor gene or of the protein-synthesis inhibitor protein with ligands permitting specific attachment to cells is introduced into the genotype of plants under the control of an active promotor, and the use of the protein-synthesis inhibitor protein obtained by introducing the protein-synthesis inhibitor gene into the bacterial overproducers for making pharmaceutical preparations.
    Type: Grant
    Filed: January 3, 1997
    Date of Patent: August 7, 2001
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschafen e.v.
    Inventors: Jeff Schell, Jürgen Logemann, Guido Jach, John Mundy
  • Patent number: 6271438
    Abstract: Transgenic pathogen-resistant organism whose genome contains at least two different genes under the control of active promoters with pathogen-inhibiting action. This organism is distinguished by a synergistic pathogen-inhibiting action. This action is evident particularly when the genes code for the gene products chitinese (ChiS, ChiG), glucanase (GluG), protein synthesis inhibitor (PSI) and antifungal protein (AFR).
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: August 7, 2001
    Inventors: Jürgen Logemann, Guido Jach, Birgit Görnhardt, John Mundy, Jeff Schell, Peter Eckes, Ilan Chet
  • Patent number: 6262338
    Abstract: The present invention relates to DNA isolated from Arachis hypogaea which encodes or hybridizes to DNA which encodes a protein that repels pests. Such DNA is useful in the transformation of vectors, host organisms and plants and for the production of plants which exhibit an increased resistance to pests.
    Type: Grant
    Filed: July 17, 1997
    Date of Patent: July 17, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Peter Schreier, Thomas Herget, Jeff Schell
  • Patent number: 6133506
    Abstract: Promoters in the 5' non-translated region of genes from Cuphea lanceota that code for .beta.-ketoacyl-(ACP) reductase are disclosed, as well as alleles and derivatives of said promoters. These promoters in the 5' non-translated region may for example be coupled with foreign genes, forming chimeric genes, and be transmitted to plants in appropriate vector systems.
    Type: Grant
    Filed: May 23, 1996
    Date of Patent: October 17, 2000
    Assignee: Max-Planck-Gesellschaft zur Forerung Der Wissenschaft E.V.
    Inventors: Reinhard Topfer, Christa Horicke-Grandpierre, Barbara Klein, Jeff Schell
  • Patent number: 6110668
    Abstract: A method of gene synthesis is disclosed. The gene synthesis method permits the codons of [m] natural gene to be changed to allow preferential transcription and translation of the synthetic gene in transgenic organisms. The method utilizes a combination of enzymatic and chemical synthesis of DNA and significantly reduces the cost, time and number of steps required for construction of synthetic genes.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: August 29, 2000
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Nicolai Strizhov, Csaba Koncz, Jeff Schell
  • Patent number: 6063601
    Abstract: Chimaeric DNA sequence which encodes: 1) a transit peptide of a cytoplasmic precursor of a chloroplast protein or polypeptide of a plant and 2) a protein or polypeptide that is heterologous to the transit peptide. The chimaeric DNA sequence can be used as a vector for transforming a plant cell so that a chimaeric precursor of the heterologous protein or polypeptide is produced in the cytoplasm of the cell and the chimaeric precursor then transports the heterologous protein or polypeptide in vivo into a chloroplast of the cell.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 16, 2000
    Assignees: Plant Genetic Systems, N.V., Bayer A.G.
    Inventors: Luis Herrera-Estrella, Guidi Van Den Broeck, Marc Van Montagu, Peter Schreier, Jeff Schell, Hans J. Bohnert, Anthony R. Cash more, Michael P. Timko, Albert P. Kausch
  • Patent number: 6043415
    Abstract: The present invention relateds to a synthetic version of a gene isolated from Bacillus thuringiensis encoding an insectidical crystal protein designated CryIC, plants transformed with the gene, and the insecticidal crystal protein toxin expressed by the gene, all of which are used to control insects of the Spodoptera species as well as those of the Mamestra species.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: March 28, 2000
    Assignees: Ramot Univ. Auth. for Applied Research and Industrial Development Ltd., Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften e.V
    Inventors: Nicolai Strizhov, Jeff Schell, Aviah Zilberstein, Menachem Keller, Baruch Sneh, Csaba Koncz
  • Patent number: 5859331
    Abstract: A modular promoter construct is described which possesses a promoter which is active in plant cells and a DNA sequence from exon 1 of the rice actin 1 gene. This modular promoter construct gives rise, where appropriate together with additional regulatory DNA sequences, to a substantial increase in gene expression in plant cells.
    Type: Grant
    Filed: February 7, 1995
    Date of Patent: January 12, 1999
    Assignee: Maxplanck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
    Inventors: Christoph Maas, Jeff Schell, Hans-Henning Steinbiss
  • Patent number: 5804184
    Abstract: Transgenic pathogen-resistant organism whose genome contains at least two different genes under the control of active promoters with pathogen-inhibiting action. This organism is distinguished by a synergistic pathogen-inhibiting action. This action is evident particularly when the genes code for the gene products chitinase (ChiS, ChiG), glucanase (GluG), protein synthesis inhibitor (PSI) and antifungal protein (AFP).
    Type: Grant
    Filed: March 6, 1997
    Date of Patent: September 8, 1998
    Assignee: Max Planck Gesellschaft Zur Furderung der Wissen Schaften, e.v.
    Inventors: Jurgen Logemann, Guido Jach, Birgit Gornhardt, John Mundy, Jeff Schell, Peter Eckes
  • Patent number: 5728925
    Abstract: Chimaeric DNA sequence which encodes: 1) a transit peptide of a cytoplasmic precursor of a chloroplast protein or polypeptide of a plant and 2) a protein or polypeptide that is heterologous to the transit peptide. The chimaeric DNA sequence can be used as a vector for transforming a plant cell so that a chimaeric precursor of the heterologous protein or polypeptide is produced in the cytoplasm of the cell and the chimaeric precursor then transports the heterologous protein or polypeptide in vivo into a chloroplast of the cell.
    Type: Grant
    Filed: April 28, 1995
    Date of Patent: March 17, 1998
    Assignees: Plant Genetic Systems, N.V., Bayer A.G.
    Inventors: Luis Herrera-Estrella, Guido Van Den Broeck, Marc Van Montagu, Peter Schreier, Jeff Schell, Hans J. Bohnert, Anthony R. Cashmore, Michael P. Timko, Albert P. Kausch
  • Patent number: 5717084
    Abstract: A chimaeric DNA sequence comprising:a) a nucleic acid sequence coding for a chimaeric protein or polypeptide comprising in sequence:1) a transit peptide of a cytoplasmatic precursor of a chloroplast protein or polypeptide of a plant species, and,2) a protein or polypeptide of interest which is different from a mature chloroplast protein or polypeptide contained in a natural cytoplasmatic precursor thereof, and,b) a promoter upstream of the nucleic acid sequence recognized by polymerases endogenous to a plant, whereby the chimaeric DNA sequence can be expressed in cells of the plant under the control of the promoter and the protein or polypeptide of interest can be translocated in the chloroplasts of the cells of the plant.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 10, 1998
    Assignees: Plant Genetic Systems, N.V., Bayer A.G.
    Inventors: Luis Herrera-Estrella, Guido Van Den Broeck, Marc Van Montagu, Peter Schreier, Jeff Schell, Hans J. Bohnert, Anthony R. Cash more, Michael P. Timko, Albert P. Kausch
  • Patent number: 5689045
    Abstract: Transgenic pathogen-resistant organism whose genome contains at least two different genes under the control of active promoters with pathogen-inhibiting action. This organism is distinguished by a synergistic pathogen-inhibiting action. This action is evident particularly when the genes code for the gene products chitinase (ChiS, ChiG), glucanase (GluG), protein synthesis inhibitor (PSI) and antifungal protein (AFP).
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: November 18, 1997
    Assignee: Max-Planck Gesellschaft zur Forderung Der Wissenschaften
    Inventors: Jurgen Logemann, Guido Jach, Birgit Gornhardt, John Mundy, Jeff Schell, Peter Eckes, Ilan Chet
  • Patent number: 5633442
    Abstract: Described are a method of producing pathogen-resistant plants in which a protein-synthesis inhibitor gene or a fusion product of the protein-synthesis inhibitor gene or of the protein-synthesis inhibitor protein with ligands permitting specific attachment to cells is introduced into the genotype of plants under the control of an active promotor, and the use of the protein-synthesis inhibitor protein obtained by introducing the protein-synthesis inhibitor gene into the bacterial overproducers for making pharmaceutical preparations.
    Type: Grant
    Filed: January 18, 1995
    Date of Patent: May 27, 1997
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.v.
    Inventors: Jeff Schell, Jurgen Logemann, Guido Jach, John Mundy
  • Patent number: RE39238
    Abstract: Transgenic pathogen-resistant organism whose genome contains at least two different genes under the control of active promoters with pathogen-inhibiting action. This organism is distinguished by a synergistic pathogen-inhibiting action. This action is evident particularly when the genes code for the gene products chitinase (ChiS, ChiG), glucanase (GluG), protein synthesis inhibitor (PSI) and antifungal protein (AFP).
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: August 15, 2006
    Assignee: Max-Planck-Gesellschaft zür Forderung der Wissenschaften e.V.
    Inventors: Jürgen Logemann, Guido Jach, Birgit Görnhardt, John Mundy, Jeff Schell, Peter Eckes, Ilan Chet